Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI.

ABSTRACT:

Background

¹⁸F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (18F-FDG PET/MRI) may improve cancer staging by combining sensitive cancer detection with high-contrast resolution and detail. We compared the diagnostic performance of 18F-FDG PET/MRI to ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) for staging oesophageal/gastro-oesophageal cancer. Following ethical approval and informed consent, participants with newly diagnosed primary oesophageal/gastro-oesophageal cancer were enrolled. Exclusions included prior/concurrent malignancy. Following 324 ± 28 MBq 18F-FDG administration and 60-min uptake, PET/CT was performed, immediately followed by integrated PET/MRI from skull base to mid-thigh.

SUBMITTER: Sharkey AR 

PROVIDER: S-EPMC8666393 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature